{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:00:12Z","timestamp":1772269212107,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Wetenschappelijk Fonds Willy Gepts"},{"name":"Strategic Growth Funding by the Research Council of the Vrije Universiteit Brussel"},{"name":"Custodian of \u2018The Two Holy Mosques' Overseas Scholarship Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40266-020-00831-5","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T02:11:54Z","timestamp":1612491114000},"page":"253-263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effect of Antihypertensive and Statin Medication Use on Muscle Performance in Community-Dwelling Older Adults Performing Strength Training"],"prefix":"10.1007","volume":"38","author":[{"given":"Mohammad","family":"Alturki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keliane","family":"Liberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Delaere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liza","family":"De Dobbeleer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerle","family":"Knoop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Mets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddhartha","family":"Lieten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bert","family":"Bravenboer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6820-9586","authenticated-orcid":false,"given":"Ivan","family":"Bautmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"831_CR1","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s12603-018-1139-9","volume":"22","author":"E Dent","year":"2018","unstructured":"Dent E, Morley JE, Arai H, Kritchevsky SB, Guralnik J, Bauer JM, et al. International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging. 2018;22:1148\u201361.","journal-title":"J Nutr Health Aging."},{"key":"831_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16\u201331.","journal-title":"Age Ageing."},{"key":"831_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.eurger.2015.12.011","volume":"7","author":"DM Mijnarends","year":"2016","unstructured":"Mijnarends DM, Schols JMGA, Halfens RJG, Meijers JMM, Luiking YC, Verlaan S, et al. Burden-of-illness of Dutch community-dwelling older adults with sarcopenia: health related outcomes and costs. Eur Geriatr Med. 2016;7:276\u201384.","journal-title":"Eur Geriatr Med."},{"key":"831_CR4","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1124\/jpet.112.191759","volume":"343","author":"M Brotto","year":"2012","unstructured":"Brotto M, Abreu EL. Sarcopenia: pharmacology of today and tomorrow. J Pharmacol Exp Ther. 2012;343:540\u20136.","journal-title":"J Pharmacol Exp Ther"},{"key":"831_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1589\/jpts.28.547","volume":"28","author":"VA Coelho","year":"2016","unstructured":"Coelho VA, Probst VS, Nogari BM, Teixeira DC, Felcar JM, Santos DC, et al. Angiotensin-II blockage, muscle strength, and exercise capacity in physically independent older adults. J Phys Ther Sci. 2016;28:547\u201352.","journal-title":"J Phys Ther Sci."},{"key":"831_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/cei.12467","volume":"179","author":"Y Chang","year":"2015","unstructured":"Chang Y, Wei W. Angiotensin II in inflammation, immunity and rheumatoid arthritis. Clin Exp Immunol. 2015;179:137\u201345.","journal-title":"Clin Exp Immunol"},{"key":"831_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10522-010-9289-0","volume":"11","author":"A Corsonello","year":"2010","unstructured":"Corsonello A, Garasto S, Abbatecola AM, Rose G, Passarino G, Mazzei B, et al. Targeting inflammation to slow or delay functional decline: where are we? Biogerontology. 2010;11:603\u201314.","journal-title":"Biogerontology"},{"key":"831_CR8","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2174\/138161212799504803","volume":"18","author":"AS Antonopoulos","year":"2012","unstructured":"Antonopoulos AS, Margaritis M, Lee R, Channon K, Antoniades C. Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Des. 2012;18:1519\u201330.","journal-title":"Curr Pharm Des."},{"key":"831_CR9","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/ageing\/afu115","volume":"43","author":"AJ Cruz-Jentoft","year":"2014","unstructured":"Cruz-Jentoft AJ, Landi F, Schneider SM, Z\u00fa\u00f1iga C, Arai H, Boirie Y, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43:748\u201359.","journal-title":"Age Ageing."},{"key":"831_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nri3041","volume":"11","author":"M Gleeson","year":"2011","unstructured":"Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol. 2011;11:607\u201315.","journal-title":"Nat Rev Immunol"},{"key":"831_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.exger.2018.10.011","volume":"114","author":"M Alturki","year":"2018","unstructured":"Alturki M, Beyer I, Mets T, Bautmans I. Impact of drugs with anti-inflammatory effects on skeletal muscle and inflammation: a systematic literature review. Exp Gerontol [Internet]. 2018;114:33\u201349. https:\/\/doi.org\/10.1016\/j.exger.2018.10.011.","journal-title":"Exp Gerontol [Internet]"},{"key":"831_CR12","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ahj.2008.10.026","volume":"157","author":"M Cesari","year":"2009","unstructured":"Cesari M, Kritchevsky SB, Atkinson HH, Penninx BW, Di Bari M, Tracy RP, et al. Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study. Am Heart J. 2009;157:334-e1.","journal-title":"Am Heart J"},{"key":"831_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jamda.2009.09.014","volume":"11","author":"M Cesari","year":"2010","unstructured":"Cesari M, Pedone C, Incalzi RA, Pahor M. ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study. J Am Med Dir Assoc. 2010;11:26\u201332.","journal-title":"J Am Med Dir Assoc."},{"key":"831_CR14","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/gerona\/gly229","volume":"74","author":"H Cao Dinh","year":"2018","unstructured":"Cao Dinh H, Njemini R, Onyema OO, Beyer I, Liberman K, De Dobbeleer L, et al. Strength endurance training but not intensive strength training reduces senescence-prone T-cells in peripheral blood in community-dwelling elderly women. J Gerontol Ser A. 2018;74:1870\u20138.","journal-title":"J Gerontol Ser A."},{"key":"831_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12979-019-0157-8","volume":"16","author":"H Cao Dinh","year":"2019","unstructured":"Cao Dinh H, Bautmans I, Beyer I, Onyema OO, Liberman K, De Dobbeleer L, et al. Six weeks of strength endurance training decreases circulating senescence-prone T-lymphocytes in cytomegalovirus seropositive but not seronegative older women. Immun Ageing. 2019;16:17.","journal-title":"Immun Ageing"},{"key":"831_CR16","unstructured":"WHO Colaborating Center for Drugs Statistics Methodology. 2020. https:\/\/www.whocc.no\/atc_ddd_index\/. Accessed 23 Oct 2020."},{"key":"831_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF03324600","volume":"17","author":"I Bautmans","year":"2005","unstructured":"Bautmans I, Mets T. A fatigue resistance test for elderly persons based on grip strength: reliability and comparison with healthy young subjects. Aging Clin Exp Res. 2005;17:217\u201322.","journal-title":"Aging Clin Exp Res."},{"key":"831_CR18","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/gerona\/gly135","volume":"74","author":"HC Dinh","year":"2019","unstructured":"Dinh HC, Bautmans I, Beyer I, Mets T, Onyema OO, Forti LN, et al. Association between immunosenescence phenotypes and pre-frailty in older subjects: does cytomegalovirus play a role? J Gerontol A Biol Sci Med Sci. 2019;74:480\u20138.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"831_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/gerona\/51A.4.M147","volume":"51","author":"P Peeters","year":"1996","unstructured":"Peeters P, Mets T. The 6-minute walk as an appropriate exercise test in elderly patients with chronic heart failure. J Gerontol Ser A Biol Sci Med Sci. 1996;51:147\u201351.","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"key":"831_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/gerona\/gls190","volume":"68","author":"GM Savva","year":"2013","unstructured":"Savva GM, Donoghue OA, Horgan F, O\u2019Regan C, Cronin H, Kenny RA. Using timed up-and-go to identify frail members of the older population. J Gerontol Ser A Biol Sci Med Sci. 2013;68:441\u20136.","journal-title":"J Gerontol Ser A Biol Sci Med Sci."},{"key":"831_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0047-6374(84)90152-0","volume":"28","author":"GJ Ligthart","year":"1984","unstructured":"Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes B, M\u00fcller-Hermelink HK, Steinmann GG. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev. 1984;28:47\u201355.","journal-title":"Mech Ageing Dev."},{"key":"831_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2318-4-6","volume":"4","author":"I Bautmans","year":"2004","unstructured":"Bautmans I, Lambert M, Mets T. The six-minute walk test in community dwelling elderly: influence of health status. BMC Geriatr. 2004;4:6.","journal-title":"BMC Geriatr."},{"key":"831_CR23","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.2174\/138161206777442137","volume":"12","author":"G Onder","year":"2006","unstructured":"Onder G, Della C, Pahor M. Effects of ACE inhibitors on skeletal muscle. Curr Pharm Des. 2006;12:2057\u201364.","journal-title":"Curr Pharm Des"},{"key":"831_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000093656","volume":"52","author":"D Sumukadas","year":"2006","unstructured":"Sumukadas D, Struthers AD, McMurdo MET. Sarcopenia - a potential target for angiotensin-converting enzyme inhibition? Gerontology. 2006;52:237\u201342.","journal-title":"Gerontology."},{"key":"831_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.cger.2011.03.008","volume":"27","author":"Y Rolland","year":"2011","unstructured":"Rolland Y, Onder G, Morley JE, Gillette-guyonet S. Current and future pharmacologic treatment of sarcopenia. Clin Geriatr Med. 2011;27:423\u201347.","journal-title":"Clin Geriatr Med."},{"key":"831_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000448247","volume":"99","author":"L Campins","year":"2017","unstructured":"Campins L, Camps M, Riera A, Pleguezuelos E, Yebenes JC, Serra-Prat M. Oral drugs related with muscle wasting. Pharmacology. 2017;99:1\u20138.","journal-title":"Pharmacology"},{"key":"831_CR27","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/BF02982709","volume":"12","author":"D Sumukadas","year":"2008","unstructured":"Sumukadas D, Witham MD, Struthers AD, Mcmurdo MET. ACE inhibitors as a therapy for sarcopenia\u2014evidence and possible mechanisms. J Nutr Health Aging. 2008;12:480.","journal-title":"J Nutr Health Aging."},{"key":"831_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1023\/A:1025387702212","volume":"17","author":"M Zi","year":"2003","unstructured":"Zi M, Carmichael N, Lye M. The effect of quinapril on functional status of elderly patients with diastolic heart failure. Cardiovasc Drugs Ther. 2003;17:133\u20139.","journal-title":"Cardiovasc Drugs Ther"},{"key":"831_CR29","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jamda.2016.03.022","volume":"17","author":"CJ George","year":"2016","unstructured":"George CJ, Verghese J. Gait performance in hypertensive patients on angiotensin-converting enzyme inhibitors. J Am Med Dir Assoc. 2016;17:737\u201340.","journal-title":"J Am Med Dir Assoc"},{"key":"831_CR30","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1111\/jgs.12029","volume":"60","author":"SL Gray","year":"2012","unstructured":"Gray SL, Aragaki AK, Lamonte MJ, Cochrane BB, Kooperberg C, Robinson JG, et al. Statins, angiotensin-converting enzyme inhibitors and physical performance in older women. Am Geriatr Soc. 2012;60:2206\u201314.","journal-title":"Am Geriatr Soc"},{"key":"831_CR31","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40266-016-0396-8","volume":"33","author":"D Spira","year":"2016","unstructured":"Spira D, Walston J, Buchmann N, Nikolov J, Demuth I, Steinhagen-Thiessen E, et al. Angiotensin-converting enzyme inhibitors and parameters of sarcopenia: relation to muscle mass, strength and function: data from the Berlin Aging Study-II (BASE-II). Drugs Aging. 2016;33:829\u201337.","journal-title":"Drugs Aging"},{"key":"831_CR32","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/j.1532-5415.2012.04045.x","volume":"60","author":"TW Buford","year":"2012","unstructured":"Buford TW, Manini TM, Hsu F-C, Cesari M, Anton SD, Nayfield S, et al. Angiotensin-converting enzyme inhibitor use by older adults is associated with greater functional responses to exercise. J Am Geriatr Soc [Internet]. 2012;60:1244\u201352. https:\/\/doi.org\/10.1111\/j.1532-5415.2012.04045.x.","journal-title":"J Am Geriatr Soc [Internet]."},{"key":"831_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.exger.2017.06.013","volume":"109","author":"LC Baptista","year":"2018","unstructured":"Baptista LC, Machado-Rodrigues AM, Ver\u00edssimo MT, Martins RA. Exercise training improves functional status in hypertensive older adults under angiotensin converting enzymes inhibitors medication. Exp Gerontol. 2018;109:82\u20139.","journal-title":"Exp Gerontol"},{"key":"831_CR34","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/gerona\/glt142","volume":"69","author":"D Sumukadas","year":"2014","unstructured":"Sumukadas D, Band M, Miller S, Cvoro V, Witham M, Struthers A, et al. Do ACE inhibitors improve the response to exercise training in functionally impaired older adults? A randomized controlled trial. J Gerontol Ser A Biol Sci Med Sci. 2014;69:736\u201343.","journal-title":"J Gerontol Ser A Biol Sci Med Sci."},{"key":"831_CR35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/08037050600911957","volume":"15","author":"E Gerdts","year":"2006","unstructured":"Gerdts E, Bj\u00f6rnstad H, Devereux RB, Lund-Johansen P, Davidsen ES, Omvik P. Exercise performance during losartan- or atenolol-based treatment in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy). Blood Press. 2006;15:220\u20136.","journal-title":"Blood Press"},{"key":"831_CR36","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1161\/CIRCULATIONAHA.105.543470","volume":"112","author":"A Multicenter","year":"2005","unstructured":"Multicenter A, Trial PC, Dore A, Houde C, Chan K, Ducharme A, et al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles. Circulation. 2005;112:2411\u20136.","journal-title":"Circulation"},{"key":"831_CR37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1177\/1358863X13497529","volume":"18","author":"AK Kurklinsky","year":"2013","unstructured":"Kurklinsky AK, Levy M. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: A randomized controlled trial. Vasc Med. 2013;18:234\u20136.","journal-title":"Vasc Med"},{"key":"831_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/ageing\/afn124","volume":"37","author":"MD Witham","year":"2008","unstructured":"Witham MD, Sumukadas D, McMurdo MET. ACE inhibitors for sarcopenia\u2014as good as exercise training? Age Ageing. 2008;37:363\u20135.","journal-title":"Age Ageing"},{"key":"831_CR39","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1111\/jgs.15065","volume":"65","author":"G McAvay","year":"2017","unstructured":"McAvay G, Allore HG, Cohen AB, Gnjidic D, Murphy TE, Tinetti ME. Guideline-recommended medications and physical function in older adults with multiple chronic conditions. J Am Geriatr Soc. 2017;65:2619\u201326.","journal-title":"J Am Geriatr Soc"},{"key":"831_CR40","volume-title":"Lecture notes on clinical pharmacology","author":"JL Reid","year":"2001","unstructured":"Reid JL, Rubin PC, Whiting B. Lecture notes on clinical pharmacology. 6th ed. Hoboken: Wiley; 2001.","edition":"6"},{"key":"831_CR41","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1001\/jamainternmed.2014.2266","volume":"174","author":"DSH Lee","year":"2014","unstructured":"Lee DSH, Markwardt S, Goeres L, Christine G, Eckstrom E, Williams C, et al. Statins and physical activity in older men: the osteoporotic fractures in men study. JAMA Intern Med. 2014;174:1263\u201370.","journal-title":"JAMA Intern Med."},{"key":"831_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/CIRCULATIONAHA.112.136101","volume":"127","author":"BA Parker","year":"2013","unstructured":"Parker BA, Capizzi JA, Grimaldi AS, Clarkson PM, Cole SM, Keadle J, et al. The effect of statins on skeletal muscle function. Circulation. 2013;127:96\u2013103.","journal-title":"Circulation"},{"key":"831_CR43","first-page":"3","volume":"33","author":"M Villafr\u00e1dez-d\u00edaz","year":"2014","unstructured":"Villafr\u00e1dez-d\u00edaz M, Santiago-casas Y, Nieves-plaza M, Vil\u00e1 LM. Association of the use of statins with disease activity and functional status in Puerto Ricans with rheumatoid arthritis. P R Health Sci J. 2014;33:3\u20138.","journal-title":"P R Health Sci J"},{"issue":"A","key":"831_CR44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/gerona\/glt140","volume":"69","author":"J Dumurgier","year":"2014","unstructured":"Dumurgier J, Singh-Manoux A, Tavernier B, Tzourio C, Elbaz A. Lipid-lowering drugs associated with slower motor decline in the elderly adults. J Gerontol Ser A Biol Sci Med Sci. 2014;69(A):199\u2013206.","journal-title":"J Gerontol Ser A Biol Sci Med Sci."},{"key":"831_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ejim.2011.06.004","volume":"23","author":"J Galindo-Oca\u00f1a","year":"2012","unstructured":"Galindo-Oca\u00f1a J, Bernabeu-Wittel M, Formiga F, Fuertes-Mart\u00edn A, Bar\u00f3n-Franco B, Murcia-Zaragoza JM, et al. Effects of renin-angiotensin blockers\/inhibitors and statins on mortality and functional impairment in polypathological patients. Eur J Intern Med [Internet]. 2012;23:179\u201384. https:\/\/doi.org\/10.1016\/j.ejim.2011.06.004.","journal-title":"Eur J Intern Med [Internet]."},{"key":"831_CR46","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/ggi.13228","volume":"18","author":"H Kawai","year":"2017","unstructured":"Kawai H, Ihara K, Kera T, Hirano H, Fujiwara Y, Tanaka M, et al. Association between statin use and physical function among community-dwelling older Japanese adults. Geriatr Gerontol Int [Internet]. 2017;18:623\u201330. https:\/\/doi.org\/10.1111\/ggi.13228.","journal-title":"Geriatr Gerontol Int [Internet]"},{"key":"831_CR47","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40266-016-0370-5","volume":"33","author":"L van Boheemen","year":"2016","unstructured":"van Boheemen L, Tett SE, Sohl E, Hugtenburg JG, van Schoor NM, Peeters GMEE. Associations between statin use and physical function in older adults from the Netherlands and Australia: Longitudinal Aging Study Amsterdam and Australian Longitudinal Study on Women\u2019s Health. Drugs Aging. 2016;33:437\u201345.","journal-title":"Drugs Aging"},{"key":"831_CR48","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1111\/j.1532-5415.2009.02566.x","volume":"57","author":"J Woo","year":"2009","unstructured":"Woo J, Leung J, Sham A, Kwok T. Defining sarcopenia in terms of risk of physical limitations: a 5-year follow-up study of 3,153 Chinese men and women. J Am Geriatr Soc. 2009;57:2224\u201331.","journal-title":"J Am Geriatr Soc"},{"key":"831_CR49","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s12603-009-0209-4","volume":"13","author":"G Onder","year":"2009","unstructured":"Onder G, Vedova CD, Landi F. Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia. JNHA J Nutr Health Aging. 2009;13:746\u201357.","journal-title":"JNHA J Nutr Health Aging."},{"key":"831_CR50","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.jacl.2017.07.003","volume":"11","author":"AM Noyes","year":"2017","unstructured":"Noyes AM, Thompson PD. The effects of statins on exercise and physical activity. J Clin Lipidol [Internet]. 2017;11:1134\u201344. https:\/\/doi.org\/10.1016\/j.jacl.2017.07.003.","journal-title":"J Clin Lipidol [Internet]."},{"key":"831_CR51","doi-asserted-by":"publisher","first-page":"e0179534","DOI":"10.1371\/journal.pone.0179534","volume":"12","author":"M Bahls","year":"2017","unstructured":"Bahls M, Gro\u00df S, Ittermann T, Busch R, Gla S, Felix SB, et al. Statins are related to impaired exercise capacity in males but not females. PLoS ONE. 2017;12:e0179534.","journal-title":"PLoS ONE"},{"key":"831_CR52","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1152\/japplphysiol.00343.2009","volume":"107","author":"MM Robinson","year":"2009","unstructured":"Robinson MM, Hamilton KL, Miller BF. The interactions of some commonly consumed drugs with mitochondrial adaptations to exercise. J Appl Physiol. 2009;107:8\u201316.","journal-title":"J Appl Physiol"},{"key":"831_CR53","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/qjmed\/hcp093","volume":"102","author":"D Scott","year":"2009","unstructured":"Scott D, Blizzard L, Fell J, Jones G. Statin therapy, muscle function and falls risk in community-dwelling older adults. QJM Int J Med. 2009;102:625\u201333.","journal-title":"QJM Int J Med"},{"key":"831_CR54","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11883-009-0075-x","volume":"12","author":"PH Joshi","year":"2010","unstructured":"Joshi PH, Jacobson TA. Therapeutic options to further lower C-reactive protein for patients on statin treatment. Curr Atheroscler Rep. 2010;12:34\u201342.","journal-title":"Curr Atheroscler Rep."},{"key":"831_CR55","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.amjcard.2006.07.079","volume":"99","author":"KG Meredith","year":"2007","unstructured":"Meredith KG, Horne BD, Pearson RR, Maycock CA, Lappe DL, Anderson JL, et al. Comparison of effects of high (80 mg) versus low (20 mg) dose of simvastatin on C-reactive protein and lipoproteins in patients with angiographic evidence of coronary arterial narrowing. Am J Cardiol. 2007;99:149\u201353.","journal-title":"Am J Cardiol"},{"key":"831_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-015-0116-0","volume":"14","author":"C Ding","year":"2015","unstructured":"Ding C, Hu M, Wu YJ, Tomlinson B. Achievement of specified lipid and high-sensitivity C-reactive protein levels with two statins in Chinese patients with hypercholesterolaemia. Lipid Health Dis [Internet]. 2015;14:1\u20137. https:\/\/doi.org\/10.1186\/s12944-015-0116-0.","journal-title":"Lipid Health Dis [Internet]"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-020-00831-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-020-00831-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-020-00831-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T02:03:44Z","timestamp":1674957824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-020-00831-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1007\/s40266-020-00831-5","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]},"assertion":[{"value":"16 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was partly funded by the Wetenschappelijk Fonds Willy Gepts of the Universitair Ziekenhuis Brussel and Strategic Growth Funding from the Research Council of the Vrije Universiteit Brussel. M. Alturki was supported by the Custodian of \u2018The Two Holy Mosques' Overseas Scholarship Program (no funding ID available).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have declared no other conflicts of interest for this article. The sponsors had no role in the design, methods, subject recruitment, data collections, analysis, or preparation of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study protocol is in accordance with the Declaration of Helsinki and was approved from the local Ethics Committee (IRB 2011\/257).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants gave written informed consent to participate.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All participants gave written informed consent for publication.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All data and material are available.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"IB and TM designed the study. All authors contributed to the data collection. MA and IB analyzed and interpreted the data. MA wrote the first draft of the manuscript and structured the figures and tables. All the authors reviewed the draft, contributed to the revision of the manuscript, and approved the final version of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}